PT Bayu Buana Tbk (IDX:BAYU)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	457,421	487,445	524,533	351,455	399,139	393,841
Market Cap Growth	-4.46%	-7.07%	49.25%	-11.95%	1.34%	-5.51%
Enterprise Value	-117,751	-118,031	55,767	-33,929	-76,099	-117,776
Last Close Price	1295.00	1284.50	1306.29	833.18	927.14	894.04
PE Ratio	4.47	4.77	7.41	8.18	776.21	233.63
PS Ratio	0.18	0.19	0.24	0.20	0.81	0.71
PB Ratio	0.90	0.99	1.16	0.85	0.88	0.99
P/TBV Ratio	0.90	0.99	1.17	0.85	0.88	1.00
P/FCF Ratio	-	3.50	6.31	-	-	4.16
P/OCF Ratio	22.78	3.15	5.86	-	-	4.03
EV/Sales Ratio	-	-	0.03	-	-	-
EV/EBITDA Ratio	-	-	0.74	-	-	-
EV/EBIT Ratio	-	-	0.80	-	-	-
EV/FCF Ratio	13.60	-	0.67	-	-	-
Debt / Equity Ratio	-	-	-	0.00	0.00	0.00
Debt / EBITDA Ratio	-	-	-	0.01	-	-
Debt / FCF Ratio	-	-	-	-	-	0.02
Asset Turnover	2.89	2.79	2.59	2.35	0.69	0.73
Inventory Turnover	-	1669.16	7524.43	29741.28	697.16	-
Quick Ratio	2.21	1.89	1.81	1.78	2.00	2.00
Current Ratio	2.36	2.02	1.87	1.85	2.06	2.07
Return on Equity (ROE)	20.91%	21.63%	16.31%	9.84%	0.07%	0.30%
Return on Assets (ROA)	7.22%	6.99%	5.22%	2.77%	-1.28%	-1.43%
Return on Capital (ROIC)	13.32%	13.73%	10.07%	4.85%	-2.14%	-2.57%
Return on Capital Employed (ROCE)	19.10%	19.50%	14.70%	7.80%	-	-
Earnings Yield	22.39%	20.96%	13.50%	12.23%	0.13%	0.43%
FCF Yield	-1.89%	28.58%	15.85%	-5.26%	-9.98%	24.06%
Dividend Yield	7.72%	7.79%	5.74%	6.00%	2.70%	8.39%
Payout Ratio	60.37%	25.93%	24.94%	20.54%	1717.28%	1047.64%
Total Shareholder Return	7.73%	7.79%	5.74%	6.00%	2.70%	8.39%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.